Federal agencies Drugs State laws

Federal drug-testing program unchanged despite new state marijuana laws: SAMHSA memo

Reprints
cannabis.jpg
Photo: Nastasic/iStockphoto

Washington — Although some state drug laws recently have been revised to legalize marijuana, the Substance Abuse and Mental Health Services Administration is reminding officials that the federal government’s Drug-Free Workplace Program has not changed.

In a one-paragraph memo sent Nov. 9 to federal drug program coordinators and federal medical review officers, Ron Flegel, director of the Division of Workplace Programs at SAMHSA’s Center for Substance Abuse Prevention, writes that the Drug-Free Workplace Program will “continue to test for Schedule I and Schedule II controlled substances at the established cut-off levels listed in the Mandatory Guidelines.”

 

Schedule I drugs include cannabis, heroin, LSD, ecstasy and peyote. Schedule II drugs include Vicodin, cocaine, methamphetamine, methadone, OxyContin, fentanyl, Adderall and Ritalin.

On Election Day, Arizona, Montana, New Jersey and South Dakota voters approved the legalization of recreational marijuana. Meanwhile, Mississippi and South Dakota joined 13 other states in legalizing marijuana for medical use.

Post a comment to this article

Safety+Health welcomes comments that promote respectful dialogue. Please stay on topic. Comments that contain personal attacks, profanity or abusive language – or those aggressively promoting products or services – will be removed. We reserve the right to determine which comments violate our comment policy. (Anonymous comments are welcome; merely skip the “name” field in the comment box. An email address is required but will not be included with your comment.)